Servicios Personalizados
Revista
Articulo
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista americana de medicina respiratoria
versión On-line ISSN 1852-236X
Resumen
JIMENEZ, Juan J y SIVORI, Martín. Comparison between the Charlson and COTE Indices in Chronic Obstructive Pulmonary Disease (COPD) and their Relationship with Mortality. Rev. am. med. respir. [online]. 2022, vol.22, n.1, pp.10-16. ISSN 1852-236X.
The morbidity and mortality of chronic obstructive pulmonary disease (COPD) is partly related to comorbidities. Many cohorts have shown that chronic comorbidities are more frequent in patients with COPD than in those without it, influencing the final prognosis of the patient.
Objective:
To compare the Charlson and CO-morbidity Test (COTE) indices and their relationship with mortality in COPD patients.
Materials and Methods:
A prospective, observational cohort followed during ten years with one visit in December 2016. The study included and evaluated patients with COPD (GOLD 2017 definition) who had comorbidities; we determined the Charlson and COTE indices and established their relationship with mortality. Conventional statistics and linear regression coefficient were used.
Results:
354 COPD patients were evaluated (age 66.5 ± 8.4, 66.7% male, 74.2% ex-smokers, 56 ± 29.7 p/y). After ten years, 220 patients were alive (62%) and 134 had died (38%). They had the following classification: GOLD 1 (10.16%), 2 (43.78%), 3 (37%), 4 (9.03%); A (9%), B (48.3%), C (0.6%) and D (41.8%); FEV1 post-bronchodilator 53.8 ± 20%. The Charlson Index was 4.1 ± 1.7 and the COTE was 0.8 ± 0. The most frequent comorbidities were hypertension (AHT) 24.2%, congestive heart failure (CHF) 12.4%, diabetes (DBT) 8.2%, cancer 7.3%, and asthma-COPD overlap syndrome (ACOS) 3.6%. The diseases with the highest mortality rate were CHF 21%, AHT 11.2%, DBT and cancer 8.2%, acute myocardial infarction (AMI) 6%, obstructive sleep apnea-hypopnea syndrome (OSAHS) and ACOS 1.5%, and atrial fibrillation (AF) 0.75% %. The COTE index correlates poorly with the Charlson index (r = 0.47). More than two-thirds of dead patients have 4 or more Charlson points. 85% of deceased patients have 1 point or less in the COTE index.
Conclusion:
Comorbidities are very frequent in moderate to severe obstruction in COPD patients, especially B and D. The most frequent are DBT and AHT. A Charlson index score of ≥ 4 more accurately discriminates mortality compared to the COTE index. There is a poor correlation between both indices.
Palabras clave : COPD; Comorbidities; Mortality; Charlson; COTE.
pdf
)
